Hantz Financial Services Inc. Grows Stock Holdings in Bruker Corporation $BRKR

Hantz Financial Services Inc. boosted its holdings in shares of Bruker Corporation (NASDAQ:BRKR) by 202.7% during the fourth quarter, Holdings Channel.com reports. The firm owned 41,306 shares of the medical research company’s stock after acquiring an additional 27,659 shares during the period. Hantz Financial Services Inc.’s holdings in Bruker were worth $1,946,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Orbis Allan Gray Ltd purchased a new stake in Bruker during the second quarter valued at $192,735,000. AQR Capital Management LLC raised its stake in Bruker by 125.3% during the second quarter. AQR Capital Management LLC now owns 3,326,820 shares of the medical research company’s stock valued at $137,065,000 after purchasing an additional 1,850,215 shares in the last quarter. Sculptor Capital LP raised its stake in Bruker by 18.3% during the second quarter. Sculptor Capital LP now owns 3,074,801 shares of the medical research company’s stock valued at $126,682,000 after purchasing an additional 476,363 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Bruker by 2.6% during the third quarter. Dimensional Fund Advisors LP now owns 1,993,201 shares of the medical research company’s stock valued at $64,745,000 after purchasing an additional 50,975 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its position in Bruker by 107.3% during the first quarter. Goldman Sachs Group Inc. now owns 1,465,319 shares of the medical research company’s stock valued at $61,162,000 after acquiring an additional 758,301 shares during the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on BRKR. Weiss Ratings cut shares of Bruker from a “sell (d+)” rating to a “sell (d)” rating in a research report on Monday, May 11th. Wall Street Zen upgraded shares of Bruker from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. The Goldman Sachs Group cut their price target on shares of Bruker from $40.00 to $35.00 and set a “sell” rating on the stock in a report on Friday, February 13th. Jefferies Financial Group set a $50.00 price target on shares of Bruker in a report on Thursday, February 12th. Finally, Stifel Nicolaus set a $45.00 price target on Bruker in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $50.54.

Bruker Trading Up 2.7%

Shares of NASDAQ BRKR opened at $46.92 on Wednesday. The company has a quick ratio of 0.72, a current ratio of 1.55 and a debt-to-equity ratio of 0.67. Bruker Corporation has a twelve month low of $28.53 and a twelve month high of $56.22. The business has a fifty day simple moving average of $38.92 and a two-hundred day simple moving average of $42.57. The firm has a market cap of $7.14 billion, a PE ratio of -195.50, a price-to-earnings-growth ratio of 2.74 and a beta of 1.12.

Bruker (NASDAQ:BRKR) last issued its earnings results on Wednesday, May 6th. The medical research company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.08. Bruker had a negative net margin of 0.65% and a positive return on equity of 11.60%. The company had revenue of $823.40 million for the quarter, compared to analysts’ expectations of $795.62 million. During the same period in the prior year, the business earned $0.47 EPS. The firm’s quarterly revenue was up 2.7% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Analysts expect that Bruker Corporation will post 2.12 earnings per share for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 7th. Investors of record on Monday, June 22nd will be paid a $0.05 dividend. The ex-dividend date is Monday, June 22nd. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. Bruker’s dividend payout ratio (DPR) is -83.33%.

Insider Buying and Selling

In related news, VP Mark Munch sold 2,000 shares of Bruker stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $39.90, for a total value of $79,800.00. Following the completion of the sale, the vice president directly owned 128,443 shares in the company, valued at $5,124,875.70. This trade represents a 1.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 27.20% of the stock is owned by company insiders.

Bruker Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.